TR201109158A2 - Eplerenon içeren kolay çözünebilen farmasötik kompozisyon. - Google Patents

Eplerenon içeren kolay çözünebilen farmasötik kompozisyon.

Info

Publication number
TR201109158A2
TR201109158A2 TR2011/09158A TR201109158A TR201109158A2 TR 201109158 A2 TR201109158 A2 TR 201109158A2 TR 2011/09158 A TR2011/09158 A TR 2011/09158A TR 201109158 A TR201109158 A TR 201109158A TR 201109158 A2 TR201109158 A2 TR 201109158A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical composition
composition containing
easily soluble
soluble pharmaceutical
containing eplerenone
Prior art date
Application number
TR2011/09158A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2011/09158A priority Critical patent/TR201109158A2/tr
Publication of TR201109158A2 publication Critical patent/TR201109158A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

Mevcut buluş, eplerenon içeren yeni, çözünebilir ve kolay üretilebilir farmasötik formülasyonlar ile ilşkilidir.
TR2011/09158A 2010-09-20 2011-09-19 Eplerenon içeren kolay çözünebilen farmasötik kompozisyon. TR201109158A2 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2011/09158A TR201109158A2 (tr) 2010-09-20 2011-09-19 Eplerenon içeren kolay çözünebilen farmasötik kompozisyon.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2010/07653A TR201007653A2 (tr) 2010-09-20 2010-09-20 Eplerenon içeren farmasötik kompozisyon
TR2011/09158A TR201109158A2 (tr) 2010-09-20 2011-09-19 Eplerenon içeren kolay çözünebilen farmasötik kompozisyon.

Publications (1)

Publication Number Publication Date
TR201109158A2 true TR201109158A2 (tr) 2012-04-24

Family

ID=45524932

Family Applications (4)

Application Number Title Priority Date Filing Date
TR2010/07653A TR201007653A2 (tr) 2010-09-20 2010-09-20 Eplerenon içeren farmasötik kompozisyon
TR2011/09160A TR201109160A2 (tr) 2010-09-20 2011-09-19 Eplerenon içeren yeni farmasötik kompozisyonlar.
TR2011/09159A TR201109159A2 (tr) 2010-09-20 2011-09-19 Eplerenon içeren film kaplı tablet kompozisyonu.
TR2011/09158A TR201109158A2 (tr) 2010-09-20 2011-09-19 Eplerenon içeren kolay çözünebilen farmasötik kompozisyon.

Family Applications Before (3)

Application Number Title Priority Date Filing Date
TR2010/07653A TR201007653A2 (tr) 2010-09-20 2010-09-20 Eplerenon içeren farmasötik kompozisyon
TR2011/09160A TR201109160A2 (tr) 2010-09-20 2011-09-19 Eplerenon içeren yeni farmasötik kompozisyonlar.
TR2011/09159A TR201109159A2 (tr) 2010-09-20 2011-09-19 Eplerenon içeren film kaplı tablet kompozisyonu.

Country Status (2)

Country Link
TR (4) TR201007653A2 (tr)
WO (1) WO2012050539A1 (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109925293B (zh) * 2019-03-15 2022-02-01 南京卡文迪许生物工程技术有限公司 依普利酮口服固体制剂及其制备方法
CN113995719B (zh) * 2021-10-19 2023-06-23 河南中盛生物工程有限公司 羧甲基纤维素钠在改善阿莫西林硫酸粘菌素注射液中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI77669C (fi) 1983-04-13 1989-04-10 Ciba Geigy Ag 20-spiroxaner och analoger, som innehaoller en oeppen ring e, foerfarande foer deras framstaellning samt dessa innehaollande farmaceutiska preparat.
UA74141C2 (uk) * 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
ES2240209T3 (es) 1999-12-08 2005-10-16 Pharmacia Corporation Composiciones de eplerenona nanoparticulada.
US20020132001A1 (en) * 2000-05-11 2002-09-19 Garthwaite Susan M. Aldosterone antagonist composition for release during aldosterone acrophase
WO2007012960A1 (en) * 2005-07-29 2007-02-01 Glenmark Pharmaceuticals Limited Pharmaceutical compositions of eplerenone
EP2124959A4 (en) * 2006-12-21 2011-09-14 Alphapharm Pty Ltd PHARMACEUTICAL COMPOSITION

Also Published As

Publication number Publication date
TR201109160A2 (tr) 2012-04-24
TR201007653A2 (tr) 2012-04-24
WO2012050539A1 (en) 2012-04-19
TR201109159A2 (tr) 2012-04-24

Similar Documents

Publication Publication Date Title
JOP20180102B1 (ar) مركب صيدلاني
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
FR2998570B1 (fr) Peptides, compositions les comprenant et utilisations notamment cosmetiques propigmentantes
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
BR112012031226A2 (pt) composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
BR112015003259A2 (pt) composto, composição farmacêutica, e, composição de vacina.
BR112013011448A2 (pt) composto, composição farnmacêutica, e, uso do composto
TR201903026T4 (tr) S100a4 anti̇korlari ve bunlarin terapöti̇k kullanimlari.
BR112015002824A2 (pt) composto, uso de um composto, composição farmacêutica, e, produto farmacêutico de combinação.
TR201821285T4 (tr) CCR3 antagonisti içeren farmasötik formülasyonlar.
FR2955770B1 (fr) Composition cosmetique.
TR201905787T4 (tr) Liyofilize TAT-NR2B9C formülasyonu.
TR201903918T4 (tr) Bir dağıtım ajanı içeren bileşimler ve bunların hazırlanması.
TR201100150A2 (tr) Suda çözünür dozaj formları
CL2013001445A1 (es) Compuestos derivados de difenilamina; composicion farmaceutica y uso en el tratamiento de enfermedades inflamatorias, tales como cancer.
BR112012002311A2 (pt) composto, composição farmacêutica, e, uso do composto.
IT1398875B1 (it) Composizioni contenti l. mucosae per uso medico.
MX359955B (es) Formulación de aroma y fragancia (iii).
MX365429B (es) Formulacion de aroma y fragancia (i).
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
WO2012093973A3 (en) Compositions in the form of tablets comprising acarbose
EP2569327A4 (en) EIF4E BINDING PEPTIDES
TR201002878A2 (tr) Sefpodoksim proksetil içeren farmasötik bileşimler.
TR201007106A1 (tr) Sefpodoksim proksetil formülasyonları.
TR201109158A2 (tr) Eplerenon içeren kolay çözünebilen farmasötik kompozisyon.